HSP90AB1 and neoplasm: Tang and colleagues showed a wide range of Hsp90 expression in different host organs which further exhibited a wide range of toxicity to an ATP-binding inhibitor and heterogenous responses against the conversional theory to the same ATP-binding inhibitor among different tumour cells.